LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors-Reference-Cited by-同舟云学术

LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors

Published:2019-08 Issue:8 Volume:28 Page:1981-1992.e7
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Egolf Shaun,Aubert Yann,Doepner Miriam,Anderson Amy,Maldonado-Lopez Alexandra,Pacella Gina,Lee Jessica,Ko Eun Kyung,Zou Jonathan,Lan Yemin,Simpson Cory L.,Ridky Todd,Capell Brian C.

Funder

National Cancer Institute

Damon Runyon Cancer Research Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Dermatology Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference75 articles.

1. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis;Alsaqer;Oncotarget,2017

2. The interplay of epigenetic marks during stem cell differentiation and development;Atlasi;Nat. Rev. Genet.,2017

3. Epigenetic control of adult stem cell function;Avgustinova;Nat. Rev. Mol. Cell Biol.,2016

4. Retinoid treatment of skin diseases;Beckenbach;Eur. J. Dermatol.,2015

5. ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes;Boxer;Genes Dev.,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics and ultraviolet radiation: Implications for skin ageing and carcinogenesis;Skin Health and Disease;2024-07-05

2. Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1;Nature Chemical Biology;2024-07-04

3. Lysine-Specific Histone Demethylase 1A Contributes to Cutaneous Psoriatic Lesions by Regulating Ferroptosis;J BIOL REG HOMEOS AG;2024

4. LSD1 drives intestinal epithelial maturation and controls small intestinal immune cell composition independent of microbiota in a murine model;Nature Communications;2024-04-22

5. Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer;Biomedicine & Pharmacotherapy;2024-04